Publications by authors named "Olivier Molinier"


Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.

J Thorac Oncol 2020 05 25;15(5):860-866. Epub 2020 Jan 25.

Department of Thoracic Oncology, AP-HP, Groupe Hospitalier HUPC, Hôpital Cochin, Paris, France; Centre de Recherche des Cordeliers, Université Paris Descartes, Complement, Inflammation and Cancer, Paris, France. Electronic address:

View Article and Find Full Text PDF
May 2020

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial.

Clin Cancer Res 2019 10 7;25(19):5759-5765. Epub 2019 Jun 7.

Department of Thoracic Oncology, Centre d'investigation clinique Institut national de la santé et de la recherche médicale 1425, Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris-Diderot University (Paris 7), Paris, France.

View Article and Find Full Text PDF
October 2019

ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.

J Thorac Oncol 2016 Oct 25;11(10):1682-9. Epub 2016 Jul 25.

Cell Biology and Biotherapy Unit, National Cancer Institute "Pascale Foundation," Institute of Hospitalization and Scientific Care (IRCCS), Naples, Italy. Electronic address:

View Article and Find Full Text PDF
October 2016

PARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase III study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

J Thorac Oncol 2014 Feb;9(2):205-13

*Department of Thoracic Oncology, Lungen Clinic Großhansdorf, Großhansdorf, Germany; †Instituto de Biomedicina de Sevilla, University Hospital Virgen del Rocío, CSIC and Seville University, Seville, Spain; ‡San Camillo-Forlanini Hospital, Rome, Italy; §Le Mans Regional Hospital, Le Mans, France; ‖Jawaharlal Nehru Cancer Hospital and Research Center, Bhopal, India; ¶University Medical Center Hamburg-Eppendorf, Hamburg, Germany; #Eli Lilly and Company, Indianapolis, Indiana; **Eli Lilly and Company, Houten, The Netherlands; and ††Division of Medical Oncology, San Giuseppe Moscati Hospital, Avellino, Italy.

View Article and Find Full Text PDF
February 2014

Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.

Lung Cancer 2012 Feb 9;75(2):213-6. Epub 2011 Aug 9.

Montpellier Academic Hospital, Service d'Oncologie Thoracique, Montpellier, France.

View Article and Find Full Text PDF
February 2012

[Small cell lung carcinoma].

Rev Prat 2003 Apr;53(7):735-42

Unité d'oncologie thoracique Hôpital Arnaud-de-Villeneuve Centre hospitalier universitaire et Languedoc Mutualité nouvelles technologies 34295 Montpellier.

View Article and Find Full Text PDF
April 2003